The human CCNDI cyclin Dl/PRADI gene was previously identified by a genetic screen for G1 cyclin function in Saccharomyces cerevisiae and also was identified as the putative BCLI oncogene. However, its role in human cell proliferation is not known. To determine if expression of human D-type cyclin genes correlates with the state of cell growth, we examined the level of mRNAs for CCNDI and a related gene, CCND3, in normal human diploid fibroblasts (HDF). The levels of both mRNAs decrease upon serum depletion or at high cell densities. Following stimulation of quiescent fibroblasts with serum, the mRNA levels increase gradually to a peak at about 12 hr, prior to the onset of S phase. Induction of cyclin gene expression by serum is reduced concomitantly with the decline in FOS induction in aging HDFs, suggesting a possible relationship to the decrease in the proliferative response to mitogens during cellular senescence. Cycloheximide partially blocks the induction of CCNDI and CCND3 gene expression by serum, suggesting that both de novo protein synthesis-dependent and -independent pathways contribute to induction. Treatment of HDFs with defied growth factors suggests a correlation between CCND mRNA induction and DNA synthesis. However, induction of these genes is not sufficient for the transition from quiescence through GI into S phase.
The proliferation of eukaryotic cells is controlled at specific points in the cell cycle, particularly at the G1 to S and the G2 to M transitions. Through a combined biochemical and genetic approach, protein complexes with protein kinase activity have been identified as key components that regulate these transitions. In the G2 to M transition, the cdc2/CDC28 protein is the catalytic subunit of the kinase, and its binding to mitotic cyclins is a prerequisite for kinase activation (1) . Similar control mechanisms seem to be involved in the G1 to S transition. In budding yeast, the accumulation of the G1 cyclins CLN1, CLN2, and CLN3 is rate limiting for CDC28 protein kinase activity and passage through a point in G1 termed START, and deletion of all the yeast CLN genes causes a lethal G1 arrest (2) . Mammalian cells have an analogous commitment point for entry into S phase, which has been termed the "restriction point" (3) . The high conservation of the cell-cycle-control machinery in eukaryotic cells suggests that, like yeast, mammalian cells possess G, cyclins .
In an effort to identify mammalian G1 cyclins, human cDNA libraries were screened for cDNAs with the ability to rescue a Saccharomyces cerevisiae mutant lacking functional CLN genes (4) (5) (6) . One of the isolated clones encoded a cyclin termed cyclin D1 that was distinct in structure from previously described cyclins (4) . The gene encoding cyclin D1, CCNDJ, is the human homolog of a mouse Ccnl gene called "CYLl" for cyclin-like (7), which was isolated as a cDNA clone from mouse macrophages stimulated by colonystimulating factor 1 (CSF-1). The gene encoding human cyclin D1 was also identified as PRADI, a gene rearranged in parathyroid tumors (8) . PRADI is closely linked to BCLI (9), a locus activated by rearrangement in some B-cell tumors where PRADI is also overexpressed, suggesting that PRADI may be the BCLI oncogene. The finding that deregulated expression of this cyclin gene may contribute to tumorigenicity suggests that cyclin D1/PRADI could be involved in the control of cell proliferation. Subsequently, two additional genes, CCND2 and CCND3, encoding human D-type cyclins D2 and D3 were isolated by low-stringency hybridization and PCR techniques (10, 11) . These genes share high sequence similarity with their murine counterparts (called "CYL2" and "CYL3" in refs. 7 and 12). All three human D-type cyclin genes encode small [33-34 kilodalton (kDa)] proteins that share an average of 57% identity over the entire coding region and 78% in the cyclin box. In this study, we asked how the expression of human D-type cyclin genes relates to the state of cell growth. As suggested by the expression of mitotic cyclins, which peak at the G2 to M transition, ifD-type cyclins are indeed G1 cyclins, their expression might peak in late G1 and be rate-limiting for the G1 to S transition. Therefore, we examined the level of D-type cyclin transcripts in quiescent human diploid fibroblasts (HDFs) stimulated with serum. We found that transcription of the CCNDI and CCND3 genes is induced by serum with kinetics characteristic of delayed early genes, peaking at 12 hr after stimulation, prior to the onset of S phase. Induction of CCND1 and CCND3 mRNAs correlates with the state of the cell growth but is not sufficient for the transition from quiescence through G1 into S phase. Plasmid Constructions. pSPD1 was constructed by inserting a Pst I-Pvu II fragment (-258 to +134) of the CCNDI genomic clone G6 (10) into pSP65. pBSD3 carries an EcoRIPst I fragment containing the first 182 base pairs (bp) of the CCND3 cDNA clone H34 (10) inserted into pBS. The human Abbreviations: HDF, human diploid fibroblast; CSF-1, colonystimulating factor 1; CHX, cycloheximide; TPA, phorbol 12-tetradecanoate 13-acetate; IBMX, isobutylmethylxanthine; MPD, mean population doublings; PDGF, platelet-derived growth factor; EGF, epidermal growth factor; FGF, fibroblast growth factor.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. c-fos (FOS) antisense plasmid (kindly provided by M. Greenberg) contains the BssHII-Xmn I fragment (-100 to +488) of the FOS gene (13) inserted into pSP64. To produce template for run-off transcripts, pSPD1 was linearized at the HindIII site, and pBSD3 and FOS plasmids were linearized at the EcoRI site of the vector polylinker sequence.
RNA Isolation and Analysis. Cytoplasmic RNA was prepared from cells by the Nonidet P-40 method and treated with DNase I (14) . Uniformly labeled riboprobes for cyclin D1 and FOS RNAs were prepared with SP6 RNA polymerase, and the riboprobe for cyclin D3 was prepared with T3 RNA polymerase (15) . Equal amounts of RNA were dissolved in 30 ,uI of 40 mM Pipes, pH 6.7/0.4 M NaCl/1 mM EDTA containing 5 X 105 cpm (Cerenkov) of each probe as indicated, denatured at 850C for 5 min, and hybridized at 600C overnight. A digestion mix (0.3 ml) of 10 mM Tris, pH 7.5/0.3 M NaCl/5 mM EDTA/40 ,ug of RNase A per ml/2 ,g of RNase T1 per ml was added and incubated at 16°C for 45 min.
Digestion was terminated by addition of 20 ,ul of 10% SDS and 5 ,ul of proteinase K at 10 mg/ml, followed by incubation at 37°C for 30 min. Samples were phenol/chloroform-extracted, ethanol-precipitated, and electrophoresed on 8% polyacrylamide/8 M urea gels. Gels were visualized by autoradiography and quantitated by exposing the dried gels to phosphor screens and analyzing with a Molecular Dynamics PhosphorImager equipped with ImageQuant software. Relative changes in the levels of specific mRNAs were highly consistent within the experimental series.
Metabolic Labeling and Cell Extract Analysis. Cells were labeled for 3 hr with 45 ,uCi (1 ,uCi = 37 kBq) of [35S]methionine (1129 Ci/mmol) per ml of methionine-free media.
Extracts from whole cells were prepared by several cycles of freezing and thawing as described (16) , and 20 ,ug of proteins were separated on 0.1% SDS/10% polyacrylamide gels. The gel was either stained with Coomassie blue or processed for fluorography.
Flow Cytometric Analysis. Cells (106) were resuspended in 0.5 ml of phosphate-buffered saline containing 1% fetal calf serum and 1 mM EDTA, fixed by gradual addition of ice-cold 80% ethanol while mixing, and stored for 1 hr at 4°C. The fixed cells were resuspended in the same buffer and stained for 30 min at 37°C with propidium iodide (Sigma) at 50 ug/ml in the presence of RNase A at 0.1 mg/ml. The fluorescence intensities of the samples were measured by quantitative flow cytometry with an Epics C system (Coulter).
Analysis of DNA Synthesis. Cells were labeled with 3 ,uCi of
[3H]thymidine (34 Ci/mmol) per ml of media for 24 hr, rinsed in phosphate-buffered saline, and then pelleted. Cell pellets were resuspended in 0.25 ml of 0.3 M NaOH and incubated on ice for 15 min. An equal volume of 209% trichloroacetic acid was added, and incubation was continued on ice for 15 min. The extracts were then passed through Whatman GF/A glass fiber filters and washed with ice-cold 10%o trichloroacetic acid followed by ice-cold 90% ethanol. Filters were dried and quantitated by liquid-scintillation counting.
RESULTS
Genes Encoding Cyclins D1 and D3 Are Differentially Expressed in Transformed and Primary Human Cells. As a first step to study the expression of D-type cyclins, various cell types were surveyed to determine whether the cyclin genes are expressed ubiquitously or in a restricted pattern. Cytoplasmic RNA isolated from growing cells was examined by RNase protection analysis with probes specific for each of the cyclin mRNAs. Although there were differences in the levels of expression, cyclin D1 RNA was expressed in most cells tested, with the exception of T-cell lines (Fig. 1, lane 4) . In contrast, cyclin D3 was expressed in all cells examined ( show D3 RNA in HepG2 cells (Fig. 1, lane 3) , it was detectable on a longer exposure of the gel. In contrast to the widely distributed pattern of expression for cyclins D1 and D3, cyclin D2 expression was highly restricted. It was detectable in two embryonal carcinomas (Tera-1 and Tera-2) and in the T-cell line H9, barely detectable in HDFs, and undetectable in a variety of other cell lines (unpublished work). In addition, the levels of D1, D2, and D3 mRNAs varied relative to each other among the different cell types. Therefore, D-type cyclin genes are differentially expressed.
Kinetics of Induction of D1 and D3 Gene Expression by
Serum in HDFs. To determine if the abundance of cyclin mRNAs changes upon reentry of quiescent cells into the cell cycle, primary fibroblast Hs68 cells were made quiescent by a 48-hr serum starvation and then were restimulated with 10% serum. RNA was prepared from the cells at various times after serum stimulation and analyzed by RNase protection analysis with probes for D1, D3, and FOS mRNAs (Fig. 2 Upper). The FOS mRNA peaked at 30 min after stimulation and was undetectable by 4 hr. In contrast, the levels ofD1 and D3 cyclin mRNAs increased gradually, peaking at about 12 hr after stimulation, and then declined slowly over the next 26 hr. Similar studies conducted in WI-38 cells gave identical results (data not shown). Nuclear run-on assays showed that the transcription rate of D1 and D3 cyclin genes increased in response to serum, but not enough to account for the increase in the steady-state mRNA levels (data not shown). Therefore, posttranscriptional regulation may also contribute to the increase in the levels of D1 and D3 mRNAs.
To determine whether induction of cyclin gene expression coincided with cell-cycle progression, flow cytometric analysis was performed on the serum-stimulated cells (Fig. 2 Lower). Ninety-two percent of the serum-starved cells were in G1 phase as estimated by DNA content. When the cells were stimulated with 10% serum, the population of cells in S phase peaked 20 hr after stimulation. Labeling with [3H]thymidine for 1-hr intervals confirmed the peak time point of S phase to be 20 hr after stimulation (data not shown). Thus, the levels of D1 and D3 cyclin mRNAs peak prior to the onset of DNA synthesis.
The delay in induction of cyclin genes relative to FOS raised the possibility that the activation of D1 and D3 gene expression might require de novo protein synthesis. To test this possibility, RNA levels were measured in cells stimulated with serum in the presence of CHX (Fig. 3) (5 ,ug) was analyzed by RNase protection assay with cDNA probes for FOS, cyclin D1, and cyclin D3 mRNAs. The same gel was exposed for 3 hr (D1) and 12 hr (D3 and FOS). (22, 23) . Similarly, young cells expressed higher levels of D1 and D3 cyclin mRNAs than did old fibroblasts in response to serum (Fig. 5, lanes 3 and 6) . Thus, the decline in the ability of aging HDFs to proliferate in response to normally mitogenic extracellular stimuli correlates with a decline in the induction of cyclin gene expression.
Expression of D1 and D3 Genes Is Not Sufficient for the Transition from Quiescence Through G, into S Phase. The observation that the D1 and D3 cyclin genes are induced by serum (Fig. 2) (Fig. 6) . Treatment with 10% serum resulted in an increase in D1 and D3 mRNA levels and [3H]thymidine incorporation, as seen previously. In contrast, upon treatment with IBMX, an inhibitor of cyclic nucleotide phosphodiesterases, and forskolin, an activator of adenylate cyclase, both the cyclin mRNA levels and [3H]thymidine incorporation declined, suggesting that activation of the cAMP pathway leads to down-regulation of cyclin gene expression and to growth arrest. Treatment with the BB form of PDGF, EGF, or FGF resulted in an increase in D1 and D3 mRNA levels as large as that produced by treatment with serum (Fig.  6A) . Similarly, treatment with the phorbol ester TPA increased cyclin mRNA levels, suggesting that activation of the protein kinase C pathway can cause the induction of cyclin genes. However, whereas treatment with the BB form of PDGF induced DNA synthesis to the same extent as serum, treatment with EGF or FGF produced only a moderate increase, and treatment with TPA produced no change in thymidine incorporation as compared with the control (Fig.  6B) . Treatment with insulin-like growth factor 1 showed no change in both cyclin mRNA levels and thymidine incorporation. Treatment with the AA form of PDGF, transforming growth factor f3, or insulin failed to induce cyclin mRNAs but resulted in small increases in thymidine incorporation. The observation that treatment with TPA induces cyclin gene expression with no effect on DNA synthesis suggests that induction of D cyclin genes is not sufficient for entry into S phase.
DISCUSSION gnal. To identify specific growth factors able to induce
Control of the commitment to DNA synthesis in mammalian i gene expression, quiescent cells were treated with cells is likely to be more complex than in yeast (24, 25) . In us agents, and cyclin mRNA levels and DNA synthesis human cells, in addition to D-type cyclins (4, 8, 10, 12) (Fig. 4) , the decrease in the induction of cyclin gene expression by serum in aging HDFs (Fig. 5) may be one of a series of events involved in the growth arrest associated with senescence. In senescent cells there is repression of two types of temporally separated growth-related genes, FOS and cyclin genes (22, 23, 28) (Fig. 5) . In contrast, an increase in the level of cAMP induces FOS expression in HDFs (23) but inhibits D1 and D3 cyclin gene expression (Fig. 6 ), indicating that FOS and cyclin D gene expression are not always linked. Like HDFs, CSF-1-dependent murine macrophages are also arrested by cAMP analogs in the G1 phase ofthe cell cycle (29) . Since cAMP does not block either CSF-1-activated signaling pathways or several immediate responses to CSF-1, including the induction of Fos and Myc mRNA (29) , cAMP-mediated growth arrest might occur later in G1 (30) . The effects of cAMP on the expression of cyclin D genes in macrophages are unknown. Since these genes are delayed early genes and may be involved in the G1 to S transition, they might be specifically targeted for repression by cAMP. Therefore, we suggest that in CSF-1-dependent murine macrophages and HDFs, cAMP might act directly on the cyclin D genes to repress their expression and that down-regulation of G1 cyclins by cAMP might be an important event contributing to the G1 block.
Our data suggest that induction of D-type cyclin gene expression is not sufficient to induce DNA synthesis. It is possible that D-type and other types ofcyclins function either together or separately during G1 and at the G1 to S transition and that cooperativity among different types of cyclins is required for the onset of DNA synthesis. It is also possible that the function of D-type cyclins is at the point of entry into the proliferative cycle, the Go/Gj boundary, and that other cyclins are required to traverse the G1 phase and induce DNA synthesis. These may be induced by signal transduction pathways that are distinct from those that induce D-type cyclin gene expression.
